Nissan Medical Industries Ltd (NISA.TA)
ILA 1371.0
(-3.92%)
ILA 1371.0
(-3.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 733.91 Million | 684.64 Million | 668.37 Million | 721.48 Million | 605.46 Million | 658.38 Million |
| Cost of Revenue | 598.13 Million | 601.37 Million | 523.95 Million | 540.03 Million | 509.89 Million | 538.83 Million |
| Gross Profit | 135.77 Million | 83.27 Million | 144.41 Million | 181.44 Million | 95.56 Million | 119.55 Million |
| Operating Expenses | 73.14 Million | 85.04 Million | 78.6 Million | 71.21 Million | 58.88 Million | 58.88 Million |
| Selling, General and Administrative Expenses | 51.08 Million | 64.66 Million | 56.38 Million | 48.41 Million | 37.2 Million | 38 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 22 Million | 146 Thousand | -66 Thousand | 102 Thousand | - | - |
| Cost and Expenses | 671.27 Million | 686.41 Million | 602.56 Million | 611.24 Million | 568.78 Million | 597.72 Million |
| Operating Income | 62.68 Million | -23.58 Million | 65.18 Million | 108.13 Million | 34.71 Million | 61.66 Million |
| Interest Expense | 21.26 Million | 10.01 Million | 7.27 Million | 9.38 Million | 12.96 Million | 13.06 Million |
| Income Tax Expense | 8.78 Million | 269 Thousand | 13.29 Million | 17.12 Million | 5.33 Million | 10.14 Million |
| Earnings before Tax | 27.82 Million | -47.01 Million | 70.44 Million | 110.01 Million | 30.91 Million | 50.56 Million |
| Net Income | 5.64 Million | -36.04 Million | 36.01 Million | 56.84 Million | 15.7 Million | 25.1 Million |
| Earnings Per Share Basic | 0.62 | -3.97 | 3.98 | 6.33 | 1.73 | 2.76 |
| Earnings Per Share Diluted | 0.62 | -3.97 | 3.93 | 6.29 | 1.73 | 2.76 |
| Weighted Average Shares Outstanding | 9.08 Million | 9.08 Million | 9.08 Million | 9.08 Million | 9.08 Million | 9.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.08 Million | 9.08 Million | 9.08 Million | 9.08 Million | 9.08 Million | 9.08 Million |
| Gross Margin | 0.19 | 0.12 | 0.22 | 0.25 | 0.16 | 0.18 |
| EBIT Margin | 0.11 | -0.01 | 0.15 | 0.20 | 0.12 | 0.13 |
| Profit Margin | 0.01 | -0.05 | 0.05 | 0.08 | 0.03 | 0.04 |
| EBITDA | 80.22 Million | -8.35 Million | 91.4 Million | 137.75 Million | 65.43 Million | 86.79 Million |
| Earnings Before Tax Margin | 0.09 | -0.03 | 0.10 | 0.15 | 0.06 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 167.65 Million | 192.53 Million | 192.34 Million | 733.91 Million | 176.46 Million | 179.98 Million |
| Cost of Revenue | 140.77 Million | 152.36 Million | 147.92 Million | 598.13 Million | 141.83 Million | 146.67 Million |
| Gross Profit | 26.88 Million | 40.17 Million | 44.42 Million | 135.77 Million | 34.63 Million | 33.3 Million |
| Operating Expenses | 17.41 Million | 18.2 Million | 19.24 Million | 73.14 Million | 17.78 Million | 17.55 Million |
| Selling, General and Administrative Expenses | 17.41 Million | 18.2 Million | -2.8 Million | - | 17.78 Million | 17.55 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 5000.00 | - | 2000.00 | -1.26 Million | -1.31 Million | -159 Thousand |
| Cost and Expenses | 158.18 Million | 170.56 Million | 167.17 Million | 671.27 Million | 159.61 Million | 164.22 Million |
| Operating Income | 10.54 Million | 22.24 Million | 23.01 Million | 62.68 Million | 17.67 Million | 16.19 Million |
| Interest Expense | 6.23 Million | 5.87 Million | -3.21 Million | 21.26 Million | 7.89 Million | 8.14 Million |
| Income Tax Expense | 870 Thousand | 2.93 Million | 1.2 Million | 8.78 Million | 5.76 Million | 1.5 Million |
| Earnings before Tax | 5.34 Million | 16.5 Million | 13.71 Million | 27.82 Million | 8.47 Million | 5.91 Million |
| Net Income | 2.62 Million | 9 Million | 7.35 Million | 5.64 Million | 467 Thousand | 1.47 Million |
| Earnings Per Share Basic | 0.28 | 0.98 | 0.78 | - | 0.05 | 0.16 |
| Earnings Per Share Diluted | 0.28 | 0.98 | 0.78 | - | 0.05 | 0.16 |
| Weighted Average Shares Outstanding | 9.35 Million | 9.18 Million | 9.41 Million | 9.08 Million | 9.08 Million | 9.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.35 Million | 9.18 Million | 9.41 Million | 9.08 Million | 9.34 Million | 9.21 Million |
| Gross Margin | 0.16 | 0.21 | 0.23 | 0.19 | 0.20 | 0.19 |
| EBIT Margin | 0.11 | 0.15 | 0.10 | - | 0.14 | 0.12 |
| Profit Margin | 0.02 | 0.05 | 0.04 | 0.01 | 0.00 | 0.01 |
| EBITDA | 19.22 Million | 29.27 Million | 18.37 Million | - | 24.09 Million | 21.94 Million |
| Earnings Before Tax Margin | 0.06 | 0.12 | 0.12 | 0.09 | 0.10 | 0.09 |
605337
LBRDK
DIFI
VET
SMFX
IDAI